Beyond Capital

Beyond Capital Ventures is a New York-based impact venture fund investing in early-stage businesses serving low-income consumers in emerging markets, primarily India and East Africa. The firm invests at seed and Series A with checks of $250k-$1M. Healthcare exposure is real and includes affordable healthcare, primary care, and consumer health products targeting low-income populations in emerging markets. Best fit: founders building affordable healthcare, primary care, or consumer health products targeted at low-income populations in India or East Africa, who would benefit from an impact-investment partner with deep emerging-markets experience; founders comfortable with an impact thesis and willing to articulate measurable outcomes for under-served populations. Entry path is the Beyond Capital website and warm intros through the New York and Nairobi impact-investing communities. Not a fit for US-payer-facing digital health, biotech therapeutics, medical devices outside emerging markets, or any company without a clear emerging-markets thesis. For an emerging-markets healthcare founder at seed or Series A, this is one of the more aligned impact doors; for US- or Europe-focused founders, this is the wrong door.